医薬品・バイオテクノロジーCRMソフトウェアの世界市場レポート 2025年

医薬品・バイオテクノロジーCRMソフトウェアの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR18.1％で170億6,000万米ドルに成長します。予測期間における成長の背景には、AIを活用した顧客インサイトの重視、バーチャル・エンゲージメント・ソリューションの拡大、ヘルスケア・エコシステムとの統合、コンプライアンスとデータ・セキュリティの確保、モバイルおよびリモート・アクセスの拡大などがあります。予測期間の主な動向には、AIを活用した顧客洞察、ヘルスケアプロバイダー向けの予測分析、患者中心のアプローチ、仮想エンゲージメントソリューション、デジタルマーケティングの重視などがあります。

個別化医療に対する需要の高まりが、当面の医薬品・バイオテクノロジーCRMソフトウェア市場の成長を牽引するとみられます。個別化医療は、遺伝的体質、環境要因、ライフスタイルに基づいて個々の患者に合わせた医療アプローチであり、集団における慢性疾患やがんの有病率の上昇により支持を集めています。カスタマイズされた医療ソリューションへの需要が高まっているため、医薬品・バイオテクノロジーCRMソフトウェアを活用して患者データを効率的に管理し、治療結果を追跡し、個別化ヘルスケアの提供を促進する必要があります。例えば、個別化医療連合（Personalized Medicine Coalition）が報告しているように、2022年には12の新しい個別化治療薬が承認され、これは新たに承認された治療全体の約34%を占め、以前に比べて大幅に増加しています。その結果、個別化医療に対する需要の急増が医薬品・バイオテクノロジーCRMソフトウェア市場の成長を促進する重要な要因となっています。

医薬品・バイオテクノロジーCRMソフトウェア市場の大手企業は、製薬およびバイオテクノロジー分野の進化するニーズに対応するため、AIを活用したパーソナライズド・エンゲージメント・プラットフォームなどのプラットフォームに人工知能（AI）や機械学習機能を統合する動きを強めています。AIを活用したパーソナライズド・エンゲージメントは、企業が医療従事者（HCP）、患者、その他の利害関係者に的を絞った適切なメッセージングを提供できるようにします。例えば、米国を拠点とする著名なクラウドベースのソフトウェア・ソリューション・プロバイダーであるセールスフォース社は、2023年10月、データ主導の自動化と信頼できるAIを通じて患者エンゲージメントと臨床業務を合理化するよう設計されたライフサイエンス・クラウドを発表しました。この革新的なソリューションにより、製薬・医療技術企業は、患者エンゲージメントの強化、臨床オペレーションの最適化、商業ライフサイクルの管理、医薬品・機器開発の旅を通じてパーソナライズされた利害関係者体験を提供できるようになります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界医薬品・バイオテクノロジーCRMソフトウェア PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の医薬品・バイオテクノロジーCRMソフトウェア市場：成長率分析
• 世界の医薬品・バイオテクノロジーCRMソフトウェア市場の実績：規模と成長, 2019-2024
• 世界の医薬品・バイオテクノロジーCRMソフトウェア市場の予測：規模と成長, 2024-2029, 2034F
• 世界医薬品・バイオテクノロジーCRMソフトウェア総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の医薬品・バイオテクノロジーCRMソフトウェア市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 人工知能による顧客関係管理（CRM）
• 従来の顧客関係管理（CRM）
• 世界の医薬品・バイオテクノロジーCRMソフトウェア市場：展開別、実績と予測, 2019-2024, 2024-2029F, 2034F
• オンプレミス
• クラウドベース
• 世界の医薬品・バイオテクノロジーCRMソフトウェア市場：企業規模別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 大企業
• 中小企業（SME）
• 世界の医薬品・バイオテクノロジーCRMソフトウェア市場：業界別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品
• バイオテクノロジー
• 世界の医薬品・バイオテクノロジーCRMソフトウェア市場人工知能による顧客関係管理（CRM）のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• AIを活用したセールスオートメーション
• AIによる顧客洞察と分析
• リードスコアリングのための予測分析
• チャットボットとバーチャルアシスタント
• 顧客とのインタラクションのための自然言語処理（NLP）
• パーソナライズされたマーケティングとキャンペーン管理
• 感情分析と顧客フィードバック分析
• 売上予測のための機械学習
• 世界の医薬品・バイオテクノロジーCRMソフトウェア市場従来の顧客関係管理（CRM）の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 連絡先とリード管理
• 営業パイプラインと商談管理
• マーケティングオートメーションとキャンペーン管理
• 顧客サービスとサポートモジュール
• メールマーケティングとコミュニケーションツール
• 顧客セグメンテーションとターゲティング
• アクティビティの追跡とレポート
• ERPやその他のビジネスシステムとの統合

第7章 地域別・国別分析

• 世界の医薬品・バイオテクノロジーCRMソフトウェア市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の医薬品・バイオテクノロジーCRMソフトウェア市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 医薬品・バイオテクノロジーCRMソフトウェア市場：競合情勢
• 医薬品・バイオテクノロジーCRMソフトウェア市場：企業プロファイル
  • Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Salesforce.com Inc. Overview, Products and Services, Strategy and Financial Analysis
  • IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Trueblue Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Cirrius Solutions Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Veeva Systems Inc.
• Aurea Software Inc.
• Indegene Private Limited
• Close-Up International Limited
• Interactive Medica S.A.
• StayinFront Inc.
• Axtria Inc.
• Navicon Consulting LLC
• Aktana Inc.
• Bpmonline
• AKA Enterprise Solutions LLC
• Anthill Agency Ltd.
• Media-Soft Inc.
• Zephyr Health Inc.
• Synergistix Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 医薬品・バイオテクノロジーCRMソフトウェア市場2029：新たな機会を提供する国
• 医薬品・バイオテクノロジーCRMソフトウェア市場2029：新たな機会を提供するセグメント
• 医薬品・バイオテクノロジーCRMソフトウェア市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Pharma and biotech CRM software is a specialized solution tailored to aid pharmaceutical and biotech companies in effectively managing customer relationships, data, and interactions. This tool is instrumental in facilitating a seamless and personalized customer experience, empowering organizations to nurture stronger relationships by gaining comprehensive insights into customer interactions.

The primary technology categories for pharma and biotech CRM software encompass artificial intelligence customer relationship management (CRM) and conventional customer relationship management (CRM). AI-driven CRM software for pharma and biotech leverages artificial intelligence and machine learning algorithms to analyze customer data, deliver valuable insights, and automate various tasks. These software solutions are deployed via on-premises or cloud-based models, catering to the needs of both large enterprises and small to medium enterprises (SMEs) operating within the pharmaceutical and biotech industries.

The pharma and biotech CRM software market research report is one of a series of new reports from The Business Research Company that provides pharma and biotech CRM software market statistics, including pharma and biotech CRM software industry global market size, regional shares, competitors with a pharma and biotech CRM software market share, detailed pharma and biotech CRM software market segments, market trends and opportunities, and any further data you may need to thrive in the pharma and biotech CRM software industry. This pharma and biotech CRM software market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharma and biotech crm software market size has grown rapidly in recent years. It will grow from $7.39 billion in 2024 to $8.76 billion in 2025 at a compound annual growth rate (CAGR) of 18.5%. The growth in the historic period can be attributed to a shift towards a customer-centric approach, expanded sales and marketing channels, increased demand for data analytics, an increased need for efficiency and productivity, and a focus on an enhanced customer experience.

The pharma and biotech crm software market size is expected to see rapid growth in the next few years. It will grow to $17.06 billion in 2029 at a compound annual growth rate (CAGR) of 18.1%. The growth in the forecast period can be attributed to emphasizing AI-powered customer insight, growing virtual engagement solutions, integrating with the healthcare ecosystem, ensuring compliance and data security, and expanding mobile and remote access. Major trends in the forecast period include AI-powered customer insights, predictive analytics for healthcare providers, a patient-centric approach, virtual engagement solutions, and an emphasis on digital marketing.

The escalating demand for personalized medicine is set to drive the growth of the pharma and biotech CRM software market in the foreseeable future. Personalized medicine, a healthcare approach tailored to individual patients based on their genetic makeup, environmental factors, and lifestyle, is gaining traction due to the rising prevalence of chronic diseases and cancer among populations. This growing demand for customized medical solutions necessitates the utilization of pharma and biotech CRM software to efficiently manage patient data, track treatment outcomes, and facilitate personalized healthcare delivery. For instance, as reported by the Personalized Medicine Coalition, 12 new personalized medications were approved in 2022, constituting approximately 34% of all newly approved treatments, signifying a substantial increase compared to previous years. Consequently, the surge in demand for personalized medicine emerges as a key driver propelling the growth of the pharma and biotech CRM software market.

Leading players in the pharma and biotech CRM software market are increasingly integrating artificial intelligence (AI) and machine learning capabilities into their platforms, such as the AI-powered personalized engagement platform, to cater to the evolving needs of the pharmaceutical and biotechnology sectors. AI-powered personalized engagement empowers companies to deliver targeted and relevant messaging to healthcare professionals (HCPs), patients, and other stakeholders. For instance, in October 2023, Salesforce, Inc., a prominent US-based provider of cloud-based software solutions, unveiled its life sciences cloud, designed to streamline patient engagement and clinical operations through data-driven automation and trusted AI. This innovative solution enables pharmaceutical and medical technology organizations to enhance patient engagement, optimize clinical operations, manage commercial lifecycles, and deliver personalized stakeholder experiences throughout the drug and device development journey.

In January 2024, Nomadia, a France-based provider of cloud-based SaaS solutions, acquired Nomadvantage for an undisclosed sum. This strategic acquisition underscores Nomadia's commitment to expanding its portfolio of cloud-based SaaS solutions and bolstering its market presence. Nomadvantage, also based in France, specializes in customer relations management software tailored to the healthcare and pharmaceutical industries, aligning with Nomadia's strategic vision to offer comprehensive solutions to meet the evolving needs of its clients in these sectors.

Major companies operating in the pharma and biotech crm software market are Oracle Corporation, Salesforce.com Inc., IQVIA Holdings Inc., Trueblue Inc., Cirrius Solutions Inc., Veeva Systems Inc., Aurea Software Inc., Indegene Private Limited, Close-Up International Limited, Interactive Medica S.A., StayinFront Inc., Axtria Inc., Navicon Consulting LLC, Aktana Inc., Bpmonline, AKA Enterprise Solutions LLC, Anthill Agency Ltd., Media-Soft Inc., Zephyr Health Inc., Synergistix Inc., Euris S.A., Inova Software Inc., Prolifiq Software Inc., Infonis International Corp., Ivy Software Development Services Pvt. Ltd.

North America was the largest region in the pharma and biotech CRM software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharma and biotech crm software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharma and biotech crm software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharma and biotech CRM software market consists of revenues earned by entities through services such as customer relationship management, sales force automation, marketing automation, mobile and remote access, and integration with the healthcare ecosystem. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharma and biotech CRM market also includes sales of lead management software, email marketing software, call centre software, event management software, and training and education software. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharma And Biotech CRM Software Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharma and biotech crm software market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharma and biotech crm software ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharma and biotech crm software market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technology: Artificial Intelligence Customer Relationship Management (CRM); Conventional Customer Relationship Management (CRM)
• 2) By Deployment: On-Premises; Cloud Based
• 3) By Enterprise Size: Large Enterprise; Small And Medium Enterprise (SMEs)
• 4) By Industry: Pharmaceuticals; Biotech
• Subsegments:
• 1) By Artificial Intelligence Customer Relationship Management (CRM): AI-Powered Sales Automation; AI-Driven Customer Insights And Analytics; Predictive Analytics For Lead Scoring; Chatbots And Virtual Assistants; Natural Language Processing (NLP) For Customer Interaction; Personalized Marketing And Campaign Management; Sentiment Analysis And Customer Feedback Analysis; Machine Learning For Sales Forecasting
• 2) By Conventional Customer Relationship Management (CRM): Contact And Lead Management; Sales Pipeline And Opportunity Management; Marketing Automation And Campaign Management; Customer Service And Support Modules; Email Marketing And Communication Tools; Customer Segmentation And Targeting; Activity Tracking And Reporting; Integration With ERP And Other Business Systems
• Companies Mentioned: Oracle Corporation; Salesforce.com Inc.; IQVIA Holdings Inc.; Trueblue Inc.; Cirrius Solutions Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharma And Biotech CRM Software Market Characteristics

3. Pharma And Biotech CRM Software Market Trends And Strategies

4. Pharma And Biotech CRM Software Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Pharma And Biotech CRM Software Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharma And Biotech CRM Software PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharma And Biotech CRM Software Market Growth Rate Analysis
• 5.4. Global Pharma And Biotech CRM Software Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharma And Biotech CRM Software Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharma And Biotech CRM Software Total Addressable Market (TAM)

6. Pharma And Biotech CRM Software Market Segmentation

• 6.1. Global Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Artificial Intelligence Customer Relationship Management (CRM)
• Conventional Customer Relationship Management (CRM)
• 6.2. Global Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• On-Premises
• Cloud Based
• 6.3. Global Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Large Enterprise
• Small And Medium Enterprise (SMEs)
• 6.4. Global Pharma And Biotech CRM Software Market, Segmentation By Industry, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceuticals
• Biotech
• 6.5. Global Pharma And Biotech CRM Software Market, Sub-Segmentation Of Artificial Intelligence Customer Relationship Management (CRM), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• AI-Powered Sales Automation
• AI-Driven Customer Insights And Analytics
• Predictive Analytics For Lead Scoring
• Chatbots And Virtual Assistants
• Natural Language Processing (NLP) For Customer Interaction
• Personalized Marketing And Campaign Management
• Sentiment Analysis And Customer Feedback Analysis
• Machine Learning For Sales Forecasting
• 6.6. Global Pharma And Biotech CRM Software Market, Sub-Segmentation Of Conventional Customer Relationship Management (CRM), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contact And Lead Management
• Sales Pipeline And Opportunity Management
• Marketing Automation And Campaign Management
• Customer Service And Support Modules
• Email Marketing And Communication Tools
• Customer Segmentation And Targeting
• Activity Tracking And Reporting
• Integration With ERP And Other Business Systems

7. Pharma And Biotech CRM Software Market Regional And Country Analysis

• 7.1. Global Pharma And Biotech CRM Software Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharma And Biotech CRM Software Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharma And Biotech CRM Software Market

• 8.1. Asia-Pacific Pharma And Biotech CRM Software Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharma And Biotech CRM Software Market

• 9.1. China Pharma And Biotech CRM Software Market Overview
• 9.2. China Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharma And Biotech CRM Software Market

• 10.1. India Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharma And Biotech CRM Software Market

• 11.1. Japan Pharma And Biotech CRM Software Market Overview
• 11.2. Japan Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharma And Biotech CRM Software Market

• 12.1. Australia Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharma And Biotech CRM Software Market

• 13.1. Indonesia Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharma And Biotech CRM Software Market

• 14.1. South Korea Pharma And Biotech CRM Software Market Overview
• 14.2. South Korea Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharma And Biotech CRM Software Market

• 15.1. Western Europe Pharma And Biotech CRM Software Market Overview
• 15.2. Western Europe Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharma And Biotech CRM Software Market

• 16.1. UK Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharma And Biotech CRM Software Market

• 17.1. Germany Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharma And Biotech CRM Software Market

• 18.1. France Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharma And Biotech CRM Software Market

• 19.1. Italy Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharma And Biotech CRM Software Market

• 20.1. Spain Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharma And Biotech CRM Software Market

• 21.1. Eastern Europe Pharma And Biotech CRM Software Market Overview
• 21.2. Eastern Europe Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharma And Biotech CRM Software Market

• 22.1. Russia Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharma And Biotech CRM Software Market

• 23.1. North America Pharma And Biotech CRM Software Market Overview
• 23.2. North America Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharma And Biotech CRM Software Market

• 24.1. USA Pharma And Biotech CRM Software Market Overview
• 24.2. USA Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharma And Biotech CRM Software Market

• 25.1. Canada Pharma And Biotech CRM Software Market Overview
• 25.2. Canada Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharma And Biotech CRM Software Market

• 26.1. South America Pharma And Biotech CRM Software Market Overview
• 26.2. South America Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharma And Biotech CRM Software Market

• 27.1. Brazil Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharma And Biotech CRM Software Market

• 28.1. Middle East Pharma And Biotech CRM Software Market Overview
• 28.2. Middle East Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharma And Biotech CRM Software Market

• 29.1. Africa Pharma And Biotech CRM Software Market Overview
• 29.2. Africa Pharma And Biotech CRM Software Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharma And Biotech CRM Software Market, Segmentation By Deployment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharma And Biotech CRM Software Market, Segmentation By Enterprise Size, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharma And Biotech CRM Software Market Competitive Landscape And Company Profiles

• 30.1. Pharma And Biotech CRM Software Market Competitive Landscape
• 30.2. Pharma And Biotech CRM Software Market Company Profiles
  • 30.2.1. Oracle Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Salesforce.com Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. IQVIA Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Trueblue Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Cirrius Solutions Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pharma And Biotech CRM Software Market Other Major And Innovative Companies

• 31.1. Veeva Systems Inc.
• 31.2. Aurea Software Inc.
• 31.3. Indegene Private Limited
• 31.4. Close-Up International Limited
• 31.5. Interactive Medica S.A.
• 31.6. StayinFront Inc.
• 31.7. Axtria Inc.
• 31.8. Navicon Consulting LLC
• 31.9. Aktana Inc.
• 31.10. Bpmonline
• 31.11. AKA Enterprise Solutions LLC
• 31.12. Anthill Agency Ltd.
• 31.13. Media-Soft Inc.
• 31.14. Zephyr Health Inc.
• 31.15. Synergistix Inc.

32. Global Pharma And Biotech CRM Software Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharma And Biotech CRM Software Market

34. Recent Developments In The Pharma And Biotech CRM Software Market

35. Pharma And Biotech CRM Software Market High Potential Countries, Segments and Strategies

• 35.1 Pharma And Biotech CRM Software Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharma And Biotech CRM Software Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharma And Biotech CRM Software Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer